SubsidieMeestersA Novel Handheld Ultrasound Medical Imaging Probe: Prototyping, Initial Validation and Business Development
The LucidWave Project aims to develop a low-cost, advanced handheld ultrasound probe for improved bedside diagnostics, enhancing medical decision-making and reducing misdiagnosis.
Projectdetails
Introduction
The LucidWave Project introduces a low-cost, very capable, handheld ultrasound probe for medical imaging based on an entirely new ultrasound technology. It aims to provide a light, but powerful imaging tool to a wide range of medical professionals for bedside, point-of-care, office, and operating room diagnostics.
Benefits
Doing so, it will bring the well-known capabilities of classic ultrasound imaging closer and faster to the patient, helping not only radiologists to make better decisions, but also GPs, nurses, and veterinarians. Consequently, much time, costs, and misdiagnosis will be saved for both patient and physician.
Objectives
The project has the following objectives:
- Starting at TRL 4, develop and deliver 2 fully functional prototypes with all parts integrated into one slim device. The capabilities will largely surpass those of current handheld devices.
- Validate the prototype’s performance in a clinical evaluation. Together with the foundations of a Quality Management System (ISO 13485), it will provide a head start for a later formal Clinical Validation according to the new Medical Device Regulation.
- Build an entrepreneurial and complementary team by inviting entrepreneurs-in-residence.
- In preparation for a start-up, a complete and quantified business plan will be created, building on a solid Value Proposition Canvas (including user-centric design) which is developed into a Business Model Canvas.
Alignment with EIC Transition Programme
LucidWave fits well into the EIC Transition Programme since it aims to develop a mature proof-of-concept (validated against state-of-the-art) into a prototype ready for Clinical Validation and for scaling up the manufacturing. The technical part is complemented with a business strategy for a new and healthy start-up.
Societal Impact
It addresses one of the key challenges and priorities of Europe, i.e., to build a healthy society.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.427.025 |
| Totale projectbegroting | € 2.427.025 |
Tijdlijn
| Startdatum | 1-7-2022 |
| Einddatum | 30-6-2025 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- KATHOLIEKE UNIVERSITEIT LEUVENpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Transition
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
LUCERO BIO: Smart Optofluidic Isolation of Spheroids for Early-Stage Drug DiscoveryLucero aims to enhance drug screening by developing a scalable 3D cell-handling platform using microfluidics and AI, enabling personalized medicine and improving treatment efficacy in pharmaceuticals. | EIC Transition | € 1.298.712 | 2023 | Details |
Advancing stroke care with cutting-edge ultrasound biomarkers for Neurocritical CareResolve Stroke aims to enhance ultrasound imaging with the SYLVER system to improve stroke diagnosis and management through innovative biomarkers, making timely detection more accessible and effective. | EIC Transition | € 2.493.436 | 2025 | Details |
EndocartoScope: Transforming any Endoscope into a Smart Device for Intraoperative 3D Localization, Navigation and MappingEndoCartoScope aims to develop a real-time 3D mapping system for endoscopy using VSLAM technology, enhancing navigation and measurement for improved diagnostics and future robotic applications. | EIC Transition | € 2.498.425 | 2025 | Details |
Fully automated cell-free DNA extraction and quantification - liquid biopsies safely from Patient to LabBiopSense aims to develop and validate a fully automated disposable cartridge for cfDNA extraction from blood, enhancing reliability and transport ease for cancer diagnostics and prenatal screening. | EIC Transition | € 2.500.000 | 2022 | Details |
Prostate Cancer Diagnosis, Localisation and Characterisation using UltrasoundPCaVision aims to enhance prostate cancer diagnosis using cost-effective ultrasound imaging and algorithms, improving patient access and reducing healthcare costs across 16 EU clinics. | EIC Transition | € 1.950.000 | 2022 | Details |
LUCERO BIO: Smart Optofluidic Isolation of Spheroids for Early-Stage Drug Discovery
Lucero aims to enhance drug screening by developing a scalable 3D cell-handling platform using microfluidics and AI, enabling personalized medicine and improving treatment efficacy in pharmaceuticals.
Advancing stroke care with cutting-edge ultrasound biomarkers for Neurocritical Care
Resolve Stroke aims to enhance ultrasound imaging with the SYLVER system to improve stroke diagnosis and management through innovative biomarkers, making timely detection more accessible and effective.
EndocartoScope: Transforming any Endoscope into a Smart Device for Intraoperative 3D Localization, Navigation and Mapping
EndoCartoScope aims to develop a real-time 3D mapping system for endoscopy using VSLAM technology, enhancing navigation and measurement for improved diagnostics and future robotic applications.
Fully automated cell-free DNA extraction and quantification - liquid biopsies safely from Patient to Lab
BiopSense aims to develop and validate a fully automated disposable cartridge for cfDNA extraction from blood, enhancing reliability and transport ease for cancer diagnostics and prenatal screening.
Prostate Cancer Diagnosis, Localisation and Characterisation using Ultrasound
PCaVision aims to enhance prostate cancer diagnosis using cost-effective ultrasound imaging and algorithms, improving patient access and reducing healthcare costs across 16 EU clinics.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
AEGEUS - A Novel EEG Ultrasound Device for Functional Brain Imaging and NeurostimulationDevelop a novel wearable device combining ultrasound imaging and EEG for enhanced diagnosis and treatment of neurological disorders, aiming for improved patient outcomes and research advancements. | EIC Pathfinder | € 2.998.988 | 2023 | Details |
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes. | EIC Accelerator | € 2.306.500 | 2024 | Details |
Cloud-native ultrasound imagingCloudSound aims to revolutionize ultrasound imaging by leveraging cloud computing for high-quality, affordable, and accessible medical imaging through a closed-loop, goal-directed approach. | ERC Proof of... | € 150.000 | 2024 | Details |
Low-cost, high-throughput quantitative phase microscopyThis project aims to develop a low-cost high-content screening platform using novel imaging technology to democratize access to advanced research tools in life sciences. | ERC Proof of... | € 150.000 | 2023 | Details |
Monitoring of stroke patients with 3D ultrasound localization microscopyThe ERC POC StrokeMonitor project aims to validate a portable super-resolution ultrasound device for monitoring delayed cerebral ischemia in stroke patients, enhancing neuroimaging accessibility and accuracy. | ERC Proof of... | € 150.000 | 2023 | Details |
AEGEUS - A Novel EEG Ultrasound Device for Functional Brain Imaging and Neurostimulation
Develop a novel wearable device combining ultrasound imaging and EEG for enhanced diagnosis and treatment of neurological disorders, aiming for improved patient outcomes and research advancements.
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""
NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes.
Cloud-native ultrasound imaging
CloudSound aims to revolutionize ultrasound imaging by leveraging cloud computing for high-quality, affordable, and accessible medical imaging through a closed-loop, goal-directed approach.
Low-cost, high-throughput quantitative phase microscopy
This project aims to develop a low-cost high-content screening platform using novel imaging technology to democratize access to advanced research tools in life sciences.
Monitoring of stroke patients with 3D ultrasound localization microscopy
The ERC POC StrokeMonitor project aims to validate a portable super-resolution ultrasound device for monitoring delayed cerebral ischemia in stroke patients, enhancing neuroimaging accessibility and accuracy.